Mercer Global Advisors
ZSAN

Mercer Global Advisors’s Zosano Pharma Corporation ZSAN Stock Holding History

Mercer Global Advisors’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,171
Closed -$293K – 1404
2020
Q3 		$293K Buy
+5,171
New +$241K ﹤0.01% 978

Other funds holding ZSAN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mercer Global Advisors's ZSAN Position: Q4 2020 in Review

Mercer Global Advisors sold out of Zosano Pharma Corporation (ZSAN) in Q4 2020, closing a stake of 5,171 shares — an estimated $293K sold.

Mercer Global Advisors first reported a position in ZSAN in Q3 2020 and held it in 1 quarter. The position peaked at $293K in Q3 2020. 34 funds tracked by Wall St. Rank hold ZSAN as of Q4 2020.

  • Mercer Global Advisors reported no remaining Zosano Pharma Corporation position as of Q4 2020 after selling out during the quarter.
  • Mercer Global Advisors sold 5,171 Zosano Pharma Corporation shares in Q4 2020, an estimated $293K.
  • Mercer Global Advisors first reported a position in Zosano Pharma Corporation in Q3 2020 and held it in 1 quarter.
  • Mercer Global Advisors's Zosano Pharma Corporation position peaked at $293K in Q3 2020.
  • 34 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q4 2020.

Based on Mercer Global Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.